SCM
BIOA

Sterling Capital Management’s BioAge Labs BIOA Stock Holding History

Sterling Capital Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Sell
651
-349
-35% -$6.3K ﹤0.01% 1985
2026
Q1 		$17.5K Sell
1,000
-367
-27% -$7.07K ﹤0.01% 2079
2025
Q4 		$18.1K Sell
1,367
-270
-16% -$2.39K ﹤0.01% 2282
2025
Q3 		$9.63K Buy
1,637
+997
+156% +$4.67K ﹤0.01% 2505
2025
Q2 		$2.64K Buy
640
+532
+493% +$2.14K ﹤0.01% 2836
2025
Q1 		$406 Sell
108
-76
-41% -$351 ﹤0.01% 2998
2024
Q4 		$1.06K Buy
+184
New +$3.17K ﹤0.01% 2930

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Sterling Capital Management's BIOA Position: Q2 2026 in Review

Sterling Capital Management reduced its BioAge Labs (BIOA) stake by 35% in Q2 2026, selling an estimated $6.3K and leaving 651 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #1985.

Sterling Capital Management first reported a position in BIOA in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.1K in Q4 2025. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Sterling Capital Management held 651 shares of BioAge Labs worth $16K as of Q2 2026.
  • Sterling Capital Management sold 349 BioAge Labs shares in Q2 2026, an estimated $6.3K.
  • BioAge Labs made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1985 holding.
  • Sterling Capital Management first reported a position in BioAge Labs in Q4 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's BioAge Labs position peaked at $18.1K in Q4 2025.
  • 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.